<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00988351</url>
  </required_header>
  <id_info>
    <org_study_id>UFIRB#384-09</org_study_id>
    <nct_id>NCT00988351</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (PAP) Titration and Treatment Versus Auto-adjusting PAP Treatment for Sleep Apnea</brief_title>
  <official_title>Portable Monitoring and APAP Treatment for Diagnosis and Treatment of OSA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>North Florida Foundation for Research and Education</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>North Florida Foundation for Research and Education</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized prospective study is to compare the efficacy of two approaches
      to initiate Positive Airway Pressure (PAP) treatment in patients diagnosed as having
      obstructive sleep apnea (OSA) by portable monitoring (PM) (limited sleep study). One pathway
      involves attended Continuous Positive Airway Pressure (CPAP) titration by PSG (full attended
      sleep study) followed by CPAP treatment. The other pathway involves treatment with
      auto-adjusting positive airway pressure (APAP)(without a titration). Study Aims: Compare PAP
      adherence, improvement in subjective sleepiness (Epworth Sleepiness Scale), reaction time
      (Psychomotor vigilance test), quality of life by the Functional Outcomes of Sleep
      Questionnaire (FOSQ), and PAP satisfaction (PAP satisfaction questionnaire) between the two
      study arms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      RESEARCH PLAN: All patients being evaluated for possible OSA are required to attend a Sleep
      Education and Evaluation Class before having a sleep study. At this class they receive
      information on sleep apnea, PAP treatment, and the types of sleep studies. They also complete
      a sleep questionnaire to identify co-existing sleep disorders and important co-morbid medical
      conditions. Screening of the sleep questionnaire and the patient's medical record is part of
      routine care to identify patients needing a diagnostic PSG and/or an attended titration. At
      the end of the class, participation in the current study will be offered the patients. Those
      signifying interest in being part of the research study and meeting inclusion and exclusion
      criteria will be contacted to participate in the study. Once they sign an informed consent
      they will be randomized to one of the two clinical pathways.

      METHODS: Study visits:

      Before informed consent (routine clinical care)

        1. Sleep Education and Evaluation Class (education about OSA, sleep studies, and OSA
           treatment). Patients complete screening sleep and medical history questionnaires.

        2. Determination of patient interest in participating in the current study and review of
           inclusion/exclusion criteria

      After informed consent

        1. PM study

        2. Randomization if the Portable monitoring (PM) study is diagnostic of OSA. If not, the
           patient will be offered a diagnostic PSG. If this is positive, they will have APAP
           treatment. If both the PM and PSG are negative for OSA the patient exits the study but
           will be followed in sleep clinic.

        3. PSG for CPAP titration (PSG arm only).

        4. CPAP/APAP setup - patient fills out Epworth Sleepiness Scale (ESS) and Functional
           Outcomes of Sleep Questionnaire (FOSQ). The same Research coordinator/Respiratory
           therapist will setup the units, fit masks, and instruct the patients on the use of their
           device. Patients being treated with CPAP or APAP will be in separate classes.

        5. Telephone contact within 7 days of setup with early intervention for PAP problems if
           needed.

        6. Clinic visit 6 weeks after starting treatment: download objective adherence, ESS, FOSQ,
           and PAP satisfaction questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive Airway Pressure Adherence (Nightly Use of Treatment)</measure>
    <time_frame>6 weeks after starting treatment</time_frame>
    <description>average nightly hours of using positive airway pressure (including 0 for nights not used)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Epworth Sleepiness Scale</measure>
    <time_frame>6 weeks after starting treatment</time_frame>
    <description>Epworth sleepiness scale (ESS) is measure of subjective sleepiness. Tendency to fall asleep in 8 situations. Total varies from zero to 24. A ESS of 10 or less is considered normal. The change in the ESS = post-treatment value - pre-treatment value. A decrease in the ESS (negative change) is consistent with less sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Functional Outcomes of Sleep Questionnaire</measure>
    <time_frame>6 weeks at clinic</time_frame>
    <description>The functional outcomes of sleep questionnaire (FOSQ) is a standard quality of life measure used to assess improvement in quality of life after treatment for sleep disorders. The total FOSQ score was analyzed. The range if 5 to 20. A higher score is a better quality of life. This analysis compares the change after treatment (post treatment FOSQ - pretreatment FOSQ). A positive difference indicates an improve in the quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual Apnea-hypopnea Index</measure>
    <time_frame>over first 6 weeks of treatment</time_frame>
    <description>The PAP device estimate of residual apnea-hypopnea index (AHI, number of apneas and hypopneas per hour of patient use) an estimate of effectiveness of treatment. An AHI &lt; 10 is considered adequate treatment and &lt;5/hour ideal treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Pressure (Level of CPAP or 90th Percentile APAP)</measure>
    <time_frame>6 weeks clinic</time_frame>
    <description>The level of CPAP used for treatment versus the 90th percentile pressure used during APAP. The 90th percentile pressure is the value that is used if one converts a patient from APAP to CPAP.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">156</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>PSG CPAP titration then CPAP treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Auto-Adjusting Positive Airway Pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous positive airway pressure</intervention_name>
    <description>continuous positive airway pressure determined by polysomnography titration</description>
    <arm_group_label>PSG CPAP titration then CPAP treatment</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Auto-adjusting positive airway pressure treatment</intervention_name>
    <description>Pressure range 4-18 centimeters of water (cm H2O)</description>
    <arm_group_label>Auto-Adjusting Positive Airway Pressure</arm_group_label>
    <other_name>AutoCPAP</other_name>
    <other_name>APAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OSA, Apnea-hypopnea index &gt; 5/hour

        Exclusion Criteria:

          -  Prior CPAP

          -  Uncontrolled Depression

          -  Moderate to Severe chronic obstructive pulmonary disease (COPD)

          -  Hypoventilation

          -  Average estimated nightly total sleep time &lt; 4 hours

          -  Shift work

          -  Unstable depression

          -  Upper airway surgery

          -  Uncontrolled Restless legs syndrome (RLS), narcolepsy

          -  Use of supplemental oxygen

          -  Severe congestive heart failure

          -  Use of nightly potent narcotics

          -  Severe obesity (BMI &gt; 40)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard B Berry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida/Malcom Randall VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Malcom Randall VA Medical Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2009</study_first_submitted>
  <study_first_submitted_qc>October 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2009</study_first_posted>
  <results_first_submitted>March 23, 2014</results_first_submitted>
  <results_first_submitted_qc>October 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 3, 2014</results_first_posted>
  <last_update_submitted>October 30, 2014</last_update_submitted>
  <last_update_submitted_qc>October 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>North Florida Foundation for Research and Education</investigator_affiliation>
    <investigator_full_name>Richard Berry</investigator_full_name>
    <investigator_title>Professor of Medicine University of Florida</investigator_title>
  </responsible_party>
  <keyword>sleep apnea</keyword>
  <keyword>positive airway pressure</keyword>
  <keyword>portable monitoring</keyword>
  <keyword>auto positive airway pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PSG CPAP Titration Then CPAP Treatment</title>
          <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
        </group>
        <group group_id="P2">
          <title>Auto-Adjusting Positive Airway Pressure</title>
          <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
                <participants group_id="P2" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>CPAP Titration</title>
              <participants_list>
                <participants group_id="P1" count="78">8 declined CPAP treatment</participants>
                <participants group_id="P2" count="78">no titration needed</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>PAP Setup</title>
              <participants_list>
                <participants group_id="P1" count="70">CPAP treatment started</participants>
                <participants group_id="P2" count="78">APAP treatment started</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Clinic Visit</title>
              <participants_list>
                <participants group_id="P1" count="64">6 lost to follow-up or no show for clinic</participants>
                <participants group_id="P2" count="69">9 lost to follow-up or no show for clinic</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Using CPAP or APAP</title>
              <participants_list>
                <participants group_id="P1" count="59">5 not using CPAP (use &lt; 1/2 hour per night)</participants>
                <participants group_id="P2" count="66">3 not using APAP (less than 1/2 hour per night)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="66"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>not using CPAP</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Apnea+hypopnea index &gt;= 10/hour</population>
      <group_list>
        <group group_id="B1">
          <title>PSG CPAP Titration Then CPAP Treatment</title>
          <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
        </group>
        <group group_id="B2">
          <title>Auto-Adjusting Positive Airway Pressure</title>
          <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="78"/>
            <count group_id="B2" value="78"/>
            <count group_id="B3" value="156"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.5" spread="11.9"/>
                    <measurement group_id="B2" value="58.3" spread="12.0"/>
                    <measurement group_id="B3" value="58.7" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="73"/>
                    <measurement group_id="B3" value="145"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <description>measure weight and height compute as kg divided by height squared</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.9" spread="6.0"/>
                    <measurement group_id="B2" value="34.2" spread="5.8"/>
                    <measurement group_id="B3" value="34.6" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>apnea+hypopnea index</title>
          <description>AHI from Home sleep apnea test</description>
          <units>number of apneas and hypopneas /hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.0" spread="19.1"/>
                    <measurement group_id="B2" value="28.6" spread="18.2"/>
                    <measurement group_id="B3" value="29.8" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Positive Airway Pressure Adherence (Nightly Use of Treatment)</title>
        <description>average nightly hours of using positive airway pressure (including 0 for nights not used)</description>
        <time_frame>6 weeks after starting treatment</time_frame>
        <population>patients using cpap or apap at clinic visit</population>
        <group_list>
          <group group_id="O1">
            <title>PSG CPAP Titration Then CPAP Treatment</title>
            <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
          </group>
          <group group_id="O2">
            <title>Auto-Adjusting Positive Airway Pressure</title>
            <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Airway Pressure Adherence (Nightly Use of Treatment)</title>
          <description>average nightly hours of using positive airway pressure (including 0 for nights not used)</description>
          <population>patients using cpap or apap at clinic visit</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.99" spread="2.3"/>
                    <measurement group_id="O2" value="4.45" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin -0.55 (mean hours of APAP arm no lower than 0.55 hours below CPAP arm)</non_inferiority_desc>
            <p_value>= 0.27</p_value>
            <p_value_desc>level of significance &lt;0.05, Power = 0.80</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.46</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.40</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-.35</ci_lower_limit>
            <ci_upper_limit>1.26</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Epworth Sleepiness Scale</title>
        <description>Epworth sleepiness scale (ESS) is measure of subjective sleepiness. Tendency to fall asleep in 8 situations. Total varies from zero to 24. A ESS of 10 or less is considered normal. The change in the ESS = post-treatment value - pre-treatment value. A decrease in the ESS (negative change) is consistent with less sleepiness.</description>
        <time_frame>6 weeks after starting treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>PSG CPAP Titration Then CPAP Treatment</title>
            <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
          </group>
          <group group_id="O2">
            <title>Auto-Adjusting Positive Airway Pressure</title>
            <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Epworth Sleepiness Scale</title>
          <description>Epworth sleepiness scale (ESS) is measure of subjective sleepiness. Tendency to fall asleep in 8 situations. Total varies from zero to 24. A ESS of 10 or less is considered normal. The change in the ESS = post-treatment value - pre-treatment value. A decrease in the ESS (negative change) is consistent with less sleepiness.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.7" spread="4.8"/>
                    <measurement group_id="O2" value="-4.1" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Patients using PAP (average of &gt;=1/2 hour per night) at 6 weeks clinic visit</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>= 0.65</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.3</ci_lower_limit>
            <ci_upper_limit>2.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Functional Outcomes of Sleep Questionnaire</title>
        <description>The functional outcomes of sleep questionnaire (FOSQ) is a standard quality of life measure used to assess improvement in quality of life after treatment for sleep disorders. The total FOSQ score was analyzed. The range if 5 to 20. A higher score is a better quality of life. This analysis compares the change after treatment (post treatment FOSQ - pretreatment FOSQ). A positive difference indicates an improve in the quality of life.</description>
        <time_frame>6 weeks at clinic</time_frame>
        <population>Using PAP 1/2 hour or more nightly</population>
        <group_list>
          <group group_id="O1">
            <title>PSG CPAP Titration Then CPAP Treatment</title>
            <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
          </group>
          <group group_id="O2">
            <title>Auto-Adjusting Positive Airway Pressure</title>
            <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Functional Outcomes of Sleep Questionnaire</title>
          <description>The functional outcomes of sleep questionnaire (FOSQ) is a standard quality of life measure used to assess improvement in quality of life after treatment for sleep disorders. The total FOSQ score was analyzed. The range if 5 to 20. A higher score is a better quality of life. This analysis compares the change after treatment (post treatment FOSQ - pretreatment FOSQ). A positive difference indicates an improve in the quality of life.</description>
          <population>Using PAP 1/2 hour or more nightly</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="3.7"/>
                    <measurement group_id="O2" value="2.6" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Patients using PAP (average &gt;=1/2 hour per nightly use) at 6 weeks clinic visit</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.33</p_value>
            <p_value_desc>&lt; 0.05 criteria for statistical significance</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.69</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.71</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.73</ci_lower_limit>
            <ci_upper_limit>2.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Residual Apnea-hypopnea Index</title>
        <description>The PAP device estimate of residual apnea-hypopnea index (AHI, number of apneas and hypopneas per hour of patient use) an estimate of effectiveness of treatment. An AHI &lt; 10 is considered adequate treatment and &lt;5/hour ideal treatment.</description>
        <time_frame>over first 6 weeks of treatment</time_frame>
        <population>participants using PAP at clinic visit (&gt;= 1/2 hour of nightly use)</population>
        <group_list>
          <group group_id="O1">
            <title>PSG CPAP Titration Then CPAP Treatment</title>
            <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
          </group>
          <group group_id="O2">
            <title>Auto-Adjusting Positive Airway Pressure</title>
            <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
          </group>
        </group_list>
        <measure>
          <title>Residual Apnea-hypopnea Index</title>
          <description>The PAP device estimate of residual apnea-hypopnea index (AHI, number of apneas and hypopneas per hour of patient use) an estimate of effectiveness of treatment. An AHI &lt; 10 is considered adequate treatment and &lt;5/hour ideal treatment.</description>
          <population>participants using PAP at clinic visit (&gt;= 1/2 hour of nightly use)</population>
          <units>events (apneas+hypopneas)/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="4.9"/>
                    <measurement group_id="O2" value="5.5" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Patients using PAP (average &gt;= 1/2 hour of nightly use) at 6 weeks clinic visit</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.49</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.12</ci_lower_limit>
            <ci_upper_limit>2.29</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Pressure (Level of CPAP or 90th Percentile APAP)</title>
        <description>The level of CPAP used for treatment versus the 90th percentile pressure used during APAP. The 90th percentile pressure is the value that is used if one converts a patient from APAP to CPAP.</description>
        <time_frame>6 weeks clinic</time_frame>
        <population>participants using PAP at the 6 weeks clinic visit</population>
        <group_list>
          <group group_id="O1">
            <title>PSG CPAP Titration Then CPAP Treatment</title>
            <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
          </group>
          <group group_id="O2">
            <title>Auto-Adjusting Positive Airway Pressure</title>
            <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Pressure (Level of CPAP or 90th Percentile APAP)</title>
          <description>The level of CPAP used for treatment versus the 90th percentile pressure used during APAP. The 90th percentile pressure is the value that is used if one converts a patient from APAP to CPAP.</description>
          <population>participants using PAP at the 6 weeks clinic visit</population>
          <units>cm H2O</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="2.5"/>
                    <measurement group_id="O2" value="10.8" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>participants using PAP (average &gt;=1/2 hour of use) at 6 weeks clinic visit</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>=0.07</p_value>
            <p_value_desc>P &lt; 0.05 considered statistically significant</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>- 0.92</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.51</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.92</ci_lower_limit>
            <ci_upper_limit>0.09</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study duration</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PSG CPAP Titration Then CPAP Treatment</title>
          <description>Patients diagnosed with sleep apnea will have a continuous positive airway pressure (CPAP) titration with polysomnography (PSG) followed by continuous positive airway pressure (CPAP) Treatment
Continuous positive airway pressure: continuous positive airway pressure determined by polysomnography titration</description>
        </group>
        <group group_id="E2">
          <title>Auto-Adjusting Positive Airway Pressure</title>
          <description>Following diagnosis of obstructive sleep apnea patients will be have auto-adjusting positive airway pressure treatment without a titration.
Auto-adjusting positive airway pressure treatment: Pressure range 4-18 centimeters of water (cm H2O)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>PAP intolerance</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="78"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>PAP treatment intolerance</sub_title>
                <description>unable to use PAP</description>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="78"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Carefully selected group with male predominance</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Richard B. Berry</name_or_title>
      <organization>Malcom Randall VA</organization>
      <phone>3522621575</phone>
      <email>Richard.Berry@medicine.ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

